Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending September 9, 2004. The report details a share repurchase transaction executed under shareholder authority granted at the Annual General Meeting on May 17, 2004, and updates regarding directors' interests in company shares.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data disclosed relates to the share buyback transaction:
- Shares Purchased: 250,000 Ordinary shares.
- Purchase Date: September 8, 2004.
- Price per Share: 1,137.4034 pence.
- Treasury Holdings Post-Purchase: 42,443,000 shares.
- Shares in Issue (excluding Treasury): 5,891,946,483 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the acquisition of 250,000 shares for Treasury. Additionally, there were minor changes in directors' interests due to the transfer of shares from the SmithKline Beecham Employee Benefit Trust to plan participants:
- 11,821 shares transferred to the GlaxoSmithKline Annual Investment Plan.
- 59 shares transferred to the SmithKline Beecham Bonus Investment Plan.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Key Facts for Investor Verification
- Verify the total cost of the 250,000 share repurchase against the stated price of 1,137.4034 pence per share.
- Confirm the updated total share count (5,891,946,483 in issue) against subsequent filings to ensure accuracy.
- Review the SmithKline Beecham Employee Benefit Trust disclosures to understand the extent of Director John Coombe's indirect interest.
- Note that this filing is a regulatory update on capital structure and does not contain quarterly or annual financial performance data.